Sources | Names Used |
---|---|
CTRPv2 | navitoclax:sorafenib (1:1 mol/mol) |
PharmacoGx | navitoclax:sorafenib (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIAA0408 | CTRPv2 | pan-cancer | AAC | 0.31 | 9e-14 |
mRNA | FXYD6 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-13 |
mRNA | YPEL1 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-13 |
mRNA | TMSB15A | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-13 |
mRNA | ZNF516 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-13 |
mRNA | DCANP1 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-13 |
mRNA | WDR7 | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-13 |
mRNA | SOGA3 | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-12 |
mRNA | RP3-403A15.5 | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-12 |
mRNA | ELAVL3 | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-12 |